---
title: "Dimethyl fumarate - Relapsing remitting multiple sclerosis"
sidebar: mydoc_sidebar
permalink: db08908-mesh-d020529-1.html
toc: false 
---


Path ID: `DB08908_MESH_D020529_1`
{% include image.html url="images/db08908-mesh-d020529-1.png" file="db08908-mesh-d020529-1.png" alt="db08908-mesh-d020529-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069462 | Dimethyl fumarate | Drug |
| REACT:R-HSA-8932339 | ROS sensing by NFE2L2 | Pathway |
| GO:0006954 | Inflammatory response | BiologicalProcess |
| MESH:D020529 | Relapsing remitting multiple sclerosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dimethyl Fumarate | POSITIVELY REGULATES | Ros Sensing By Nfe2L2 |
| Ros Sensing By Nfe2L2 | NEGATIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Relapsing Remitting Multiple Sclerosis |
|---------|-----------|---------|

Comment: Dimethyl fumarate ia a prodrug which is metabolised into the pharmacologically active monomethyl fumarate. The mechanism of action of dimethyl fumarate in multiple sclerosis is not well understood.

Reference: [https://go.drugbank.com/drugs/DB08908#mechanism-of-action](https://go.drugbank.com/drugs/DB08908#mechanism-of-action){:target="_blank"}